Gland Pharma
GLAND.NS
$21.20
Share price
0.32%
Change (1 day)
41.15%
Change (1 year)
Categories
Operating Margin for Gland Pharma (GLAND.NS)
Operating Margin as of April 2024 (TTM): 25.62%
According to Gland Pharma 's latest financial reports and stock price the company's current Operating Margin is 25.62%. At the end of 2023 the company had an Operating Margin of 29.10%.
Operating Margin history for Gland Pharma from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 29.10% | -21.19% |
| 2022 | 36.92% | -5.31% |
| 2021 | 38.99% | 0.99% |
| 2020 | 38.61% | 12.12% |
| 2019 | 34.43% | 8.49% |
| 2018 | 31.74% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.